After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

From timing dissolving treatments to post-procedure recovery, discover how aesthetic specialists fix overdone filler and ...

A one-time gene therapy called AMT-130 helped slow the progression of Huntington's disease by 75%, paving the way for the ...

An experimental drug is being tested right now in Chicago at the Shirley Ryan Ability Lab is showing promising results.

Ajovy is one of the CGRP inhibitors used for migraine prevention. Approved for ages 6 and up, it's noted for its safety, tolerability, and benefits seen within the first month.

Novo Nordisk has submitted an application to the FDA seeking approval of Mim8 for the treatment of people with hemophilia A.